Real-time disaster intelligence, alerts, and response tools.
Wednesday, March 4, 2026
[ad_1] The growing number of medical conditions that require frequent check-ups is likely boosting the telemedicine market. Regular therapy sessions, psychiatric consultations, children’s frequent health checks for vaccinations and growth monitoring, and ongoing evaluation and […]
[ad_1] NEW YORK, Oct. 3, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover […]
[ad_1] NEW YORK , Oct. 3, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Spire Global, Inc. (“Spire Global” or the “Company”) (NYSE: SPIR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks […]
[ad_1] The European Commission has granted conditional approval for Ipsen’s IQIRVO (elafibranor) for the treatment of primary biliary cholangitis in adults, marking the first new therapy for this condition to be approved in the EU […]
[ad_1] NEW YORK, Oct. 1, 2024 /PRNewswire/ — The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Cepton, Inc (“CPTN” or the “Company”) (NASDAQ: CPTN) stock purchased on […]
